REGISTERED
on 27 Jul 2021
Last Applicant/ Owned by
828 Winter Street, Suite 300
Waltham
MA
02451
Serial Number
88981673 filed on 03rd Feb 2020
Registration Number
6435654 registered on 27th Jul 2021
Correspondent Address
Valerie Brennan
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
XILIO
Pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer, all of the foregoing excluding research and development services for pharmaceutical products for sleep disorders, central nervous disorders (other than cancers of the central nervous system), and neurological disorders (other than cancers of the neurological system)
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; research and development of pharmaceuticals for the treatment of cancer, all of the foregoing excluding research and development services for pharmaceutical products for sleep disorders, central nervous disorders (other than cancers of the central nervous system), and neurological disorders (other than cancers of the neurological system)
First Use Date in General
02th Mar 2021
First Use Date in Commerce
02th Mar 2021
Mark Details
Serial Number
No 88981673
Mark Type
No Service Mark
Attorney Docket Number
No Xilio
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Feb 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 27th Feb 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 27th Feb 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 27th Jul 2021 | REGISTERED-PRINCIPAL REGISTER |
| 23rd Jun 2021 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 22nd Jun 2021 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 19th May 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 18th May 2021 | DIVISIONAL PROCESSING COMPLETE |
| 18th May 2021 | SOU EXTENSION 1 GRANTED |
| 18th May 2021 | STATEMENT OF USE PROCESSING COMPLETE |